Blood‐based biomarkers for Alzheimer's disease-Reference-Cited by-同舟云学术

Blood‐based biomarkers for Alzheimer's disease

Published:2022-10 Issue:4 Volume:26 Page:10-14
ISSN:1367-7543
Container-title:Progress in Neurology and Psychiatry
language:en
Short-container-title:Prog Neurol Psychiatry

Author:

Chohan Priyanka¹,Dashwood Mark²,Theodoulou George³,Reed Hannah³,Kuruvilla Tarun⁴

Affiliation:

1. Priyanka Chohan is a Physician Associate in Child and Adolescent Mental health Services (CAMHS) at Leicester Partnership NHS Trust

2. Dr Dashwood is an Old Age Psychiatry Registrar at Gloucestershire Health and Care (GHC) NHS Foundation Trust

3. Dr Theodoulou is a Honorary Senior Lecturer at University of Worcester; Dr Reed is a course leader and lecturer on the MSc Physician Associate course at University of Worcester

4. Professor Kuruvilla is a Consultant Psychiatrist at GHC and Visiting Professor with the School of Health & Social Care at the University of Gloucestershire.

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pnp.764

Reference36 articles.

1. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia

2. Using biomarkers to improve detection of Alzheimer’s disease

3. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

4. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

5. National Institute for Health and Care Excellence (NICE). Dementia: assessment management and support for people living with dementia and their carers. NICE guideline [NG97] (www.nice.org.uk/guidance/ng97;accessed 29 September 2022).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lecanemab for Alzheimer's disease: new hope or another false dawn?;Progress in Neurology and Psychiatry;2023-01